{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:55:19Z","timestamp":1793944519738,"version":"4.8.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"European Agency for Health and Consumers","award":["20111202"],"award-info":[{"award-number":["20111202"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Juvenile systemic sclerosis (JSSc) is a rare disease of childhood and currently no international consensus exists with regard to its assessment and treatment. This SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) initiative, based on expert opinion informed by the best available evidence, provides recommendations for the assessment and treatment of patients with JSSc with a view to improving their outcome. Experts focused attention not only on the skin assessment but also on the early signs of internal organ involvement whose proper treatment can significantly affect the long-term outcome. A score for disease severity is proposed in order to perform a structured assessment of outcome over time but a validation in a wider patient population is recommended. Finally, a stepwise treatment approach is proposed in order to unify the standard of care throughout Europe with the aim to reduce morbidity and mortality in this disease.<\/jats:p>","DOI":"10.1093\/rheumatology\/keaa584","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T15:12:49Z","timestamp":1598368369000},"page":"1651-1658","source":"Crossref","is-referenced-by-count":58,"title":["Consensus-based recommendations for the management of juvenile systemic sclerosis"],"prefix":"10.1093","volume":"60","author":[{"given":"Ivan","family":"Foeldvari","sequence":"first","affiliation":[{"name":"Hamburger Zentrum f\u00fcr Kinder- und Jugendrheumatologie, Schoen Clinic, Hamburg-Eilbek, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Culpo","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health, University of Padova, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sperotto","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health, University of Padova, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Anton","sequence":"additional","affiliation":[{"name":"Hospital Sant Joan de D\u00e9u, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Avcin","sequence":"additional","affiliation":[{"name":"Department of Allergy, Rheumatology and Clinical Immunology, University Children\u2019s Hospital, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Baildam","sequence":"additional","affiliation":[{"name":"Clinical and Academic Paediatric and Adolescent Rheumatology Unit, Alder Hey Children\u2019s NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Boros","sequence":"additional","affiliation":[{"name":"Rheumatology, Women\u2019s and Children\u2019s Hospital, University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Chaitow","sequence":"additional","affiliation":[{"name":"Rheumatology, The Children's Hospital Westmead, Australia, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Constantin","sequence":"additional","affiliation":[{"name":"2nd Department of Pediatrics, Semmelweis Hospital, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Knupp Feitosa de Oliveira","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology Unit, Instituto de Puericultura e Pediatria Martag\u00e3o Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Pilkington","sequence":"additional","affiliation":[{"name":"Centre for Adolescent Rheumatology, Institute of Child Health University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Toplak","sequence":"additional","affiliation":[{"name":"Department of Allergy, Rheumatology and Clinical Immunology, University Children\u2019s Hospital, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"van Royen","sequence":"additional","affiliation":[{"name":"Paediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Saad Magalhaes","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Faculdade de Medicina de Botucatu, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan J","family":"Vastert","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, Wilhelmina Children's Hospital, Utrecht, The Netherlands"},{"name":"The European Reference Network RITA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Wulffraat","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, Wilhelmina Children's Hospital, Utrecht, The Netherlands"},{"name":"The European Reference Network RITA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-3485","authenticated-orcid":false,"given":"Francesco","family":"Zulian","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health, University of Padova, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"2021040620372469600_keaa584-B1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1546-0096-11-5","article-title":"Time to share","volume":"11","author":"Wulffraat","year":"2013","journal-title":"Ped Rheum Online J"},{"key":"2021040620372469600_keaa584-B2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.22551","article-title":"The Pediatric Rheumatology European Society\/American College of Rheumatology\/European League Against Rheumatism Provisional Classification Criteria for Juvenile Systemic Sclerosis","volume":"57","author":"Zulian","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021040620372469600_keaa584-B3","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees","volume":"63","author":"Dougados","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2021040620372469600_keaa584-B4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214697","article-title":"Consensus-based recommendations for the management of juvenile localized scleroderma","volume":"78","author":"Zulian","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021040620372469600_keaa584-B5","first-page":"655","article-title":"How to use the nominal group and Delphi techniques","volume":"38","author":"McMillan","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"2021040620372469600_keaa584-B6","first-page":"771","volume-title":"Oxford textbook of rheumatology","author":"Black","year":"1993"},{"key":"2021040620372469600_keaa584-B7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pcl.2005.02.001","article-title":"Scleroderma in children","volume":"52","author":"Zulian","year":"2005","journal-title":"Pediatr Clin N Am"},{"key":"2021040620372469600_keaa584-B8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","article-title":"Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland","volume":"62","author":"Herrick","year":"2010","journal-title":"Arthritis Care Res"},{"key":"2021040620372469600_keaa584-B9","first-page":"189","article-title":"Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States","volume":"3","author":"Beukelman","year":"2018","journal-title":"J Sclerod Rel Dis"},{"key":"2021040620372469600_keaa584-B10","first-page":"200","article-title":"Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring","volume":"34 (Suppl 100","author":"Pain","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2021040620372469600_keaa584-B11","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s00296-011-2109-2","article-title":"Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud\u2019s phenomenon","volume":"32","author":"Pavlov-Dolijanovic","year":"2012","journal-title":"Rheumatol Int"},{"key":"2021040620372469600_keaa584-B12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1525-1470.2006.00278.x","article-title":"The prognostic value of nailfold capillary changes forthe development of connective tissuedisease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients","volume":"23","author":"Pavlov-Dolijanovi\u0107","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"2021040620372469600_keaa584-B13","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1002\/art.22207","article-title":"Systemic sclerosis in childhood: clinical and immunological features of 153 patients in an international database","volume":"54","author":"Martini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021040620372469600_keaa584-B14","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/acr.23547","article-title":"Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis","volume":"70","author":"Stevens","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2021040620372469600_keaa584-B15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.111.4.715","article-title":"Raynaud's phenomenon in children: a retrospective review of 123 patients","volume":"111","author":"Nigrovic","year":"2003","journal-title":"Pediatrics"},{"key":"2021040620372469600_keaa584-B16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/rheumatology\/31.7.457","article-title":"Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group","volume":"31","author":"Brennan","year":"1992","journal-title":"Br J Rheumatol"},{"key":"2021040620372469600_keaa584-B17","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2021040620372469600_keaa584-B18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/rheumatology\/kei106","article-title":"Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score","volume":"45","author":"Foeldvari","year":"2006","journal-title":"Rheumatology"},{"key":"2021040620372469600_keaa584-B19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/rheumatology\/ken388","article-title":"Factors affecting survival in Juvenile Systemic Sclerosis","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology"},{"key":"2021040620372469600_keaa584-B20","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1002\/art.34652","article-title":"A preliminary disease severity score for juvenile systemic sclerosis","volume":"64","author":"La Torre","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021040620372469600_keaa584-B21","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/ppul.21141","article-title":"HRCT and pulmonary function tests in monitoring of lung involvement in juvenile systemic sclerosis","volume":"44","author":"Panigada","year":"2009","journal-title":"Pediat Pulmonol"},{"key":"2021040620372469600_keaa584-B22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021040620372469600_keaa584-B23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021040620372469600_keaa584-B24","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021040620372469600_keaa584-B25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/BOR.0b013e3283641f61","article-title":"Scleroderma in children: an update","volume":"25","author":"Zulian","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"2021040620372469600_keaa584-B26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2021040620372469600_keaa584-B27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpeds.2013.10.029","article-title":"Methotrexate: new uses for an old drug","volume":"164","author":"Hashkes","year":"2014","journal-title":"J Pediatr"},{"key":"2021040620372469600_keaa584-B28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3899\/jrheum.111229","article-title":"A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset","volume":"39","author":"Mendoza","year":"2012","journal-title":"J Rheumatol"},{"key":"2021040620372469600_keaa584-B29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2021040620372469600_keaa584-B30","first-page":"49","article-title":"Characteristics of the first 80 patients included in the juvenile systemic sclerosis inception cohort","volume":"4","author":"Foeldvari","year":"2019","journal-title":"J Sclerod Rel Dis"},{"key":"2021040620372469600_keaa584-B31","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"2021040620372469600_keaa584-B32","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/art.22204","article-title":"A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma","volume":"54","author":"Hoyles","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021040620372469600_keaa584-B33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/rheumatology\/keg480","article-title":"Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases","volume":"43","author":"Zulian","year":"2003","journal-title":"Rheumatology"},{"key":"2021040620372469600_keaa584-B34","first-page":"105","article-title":"Iloprost treatment for refractory Raynaud\u2019s phenomenon in two infants","volume":"26","author":"Shouval","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2021040620372469600_keaa584-B35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/rheumatology\/ken001","article-title":"Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients","volume":"47","author":"Garc\u00eda de la Pe\u00f1a-Lefebvre","year":"2007","journal-title":"Rheumatology ("},{"key":"2021040620372469600_keaa584-B36","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/rheumatology\/key213","article-title":"Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial","volume":"57","author":"Sircar","year":"2018","journal-title":"Rheumatology"},{"key":"2021040620372469600_keaa584-B37","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","article-title":"Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group","volume":"74","author":"Jordan","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021040620372469600_keaa584-B38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/annrheumdis-2017-211682","article-title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)","volume":"77","author":"Khanna","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021040620372469600_keaa584-B39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.berh.2019.01.011","article-title":"Outcomes of patients with systemic sclerosis treated with tocilizumab: case series and review of the literature","volume":"32","author":"Zacay","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2021040620372469600_keaa584-B40","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1093\/rheumatology\/keaa193","article-title":"Rituximab for rapidly progressive juvenile systemic sclerosis","volume":"59","author":"Zulian","year":"2020","journal-title":"Rheumatology"},{"key":"2021040620372469600_keaa584-B41","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/BOR.0000000000000553","article-title":"T cells and cytokines in systemic sclerosis","volume":"30","author":"Fuschiotti","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2021040620372469600_keaa584-B42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"key":"2021040620372469600_keaa584-B43","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","article-title":"Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for Blood and Marrow Transplantation","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021040620372469600_keaa584-B44","first-page":"795","article-title":"Serum Level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis","volume":"31","author":"Vesel\u00fd","year":"2004","journal-title":"J Rheumatol"},{"key":"2021040620372469600_keaa584-B45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3899\/jrheum.080633","article-title":"Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1651\/36912813\/keaa584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1651\/36912813\/keaa584.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:39:50Z","timestamp":1617737990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/4\/1651\/5956234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,11,4]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa584","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,11,4]]}}}